Connect with us

Stocks

And that’s a wrap: The Market Herald at PDAC 2022

The first in person Prospectors & Developers Association of Canada (PDAC) Convention…
The post And that’s a wrap: The Market Herald at PDAC 2022…

Published

on

  • The first in person Prospectors & Developers Association of Canada (PDAC) Convention since March 2020 was held earlier this month
  • More than 1,700 investors, analysts, mining executives, geologists, and government officials attended
  • The Market Herald interviewed dozens of the world’s mineral exploration and mining industry leaders

The world’s premier mineral exploration and mining convention, the Prospectors and Developers Association of Canada (PDAC) welcomed a massive crowd of more than 17,000 back to Toronto for its first in person convention since March 2020.

Confirming the mining sector’s hunger for returning to business, the 90th annual convention was a robust and busy affair with a jammed packed line-up of speakers and workshops.

The mining sector has been enduring and overcoming challenges this year, chief among them geopolitical challenge like revolving governments and resource nationalism.

Even so, a recent survey of miners found that an overwhelming majority expect royalties to increase.

How would operators mitigate future risks and work to stabilize the supply chain? What of the other factors bucking the trend when it comes to the mining industry? These were the questions on the minds of many PDAC 2022 attendees and The Market Herald Team caught up with dozens of leaders and executives from top mining companies working in various corners of the world to learn more about the potential they seek to unearth.

Highlights:

Tonno Vahk, CEO of Aton Resources (TSXV:AAN) discussed the latest results of their diamond drilling program.

Developing the Mon Gold Property in the Yellowknife Gold Belt District, 60 North Gold (CSE:SXTY) Vice President, Corporate Development, Ronald Handford, spoke about recent bulk samples taken to give the team a sense of mineral grades.

Engaged in the business of mineral exploration, CAVU Energy Metals (CSE:CAVU) has been drilling since early May 2022 at its Yukon Copper Project, home to its porphyry copper, gold, silver and molybdenum project with first assays at lab. The company’s CEO, Jacob Verbaas, spoke about the large copper systems at its Yukon Copper and Star Projects.

Chris Eager, President and CEO of Resouro Gold (TSXV:RAU), spoke about mobilizing a team and drill rig for its Novo Mundo Gold Project in Brazil.

CEO of Atex Resources (TSXV:ATX), Raymond Jannas, spoke about new and impressive gold-copper results from the Valeriano Project in Chile.

Search Minerals (TSXV:SMY) plans to be in production of Critical Rare Earths Elements (CREE) in three years, specifically permanent magnet REEs. The company’s President and CEO, Greg Andrews, spoke about his team’s next steps.

President and CEO of Millrock Resources (TSXV:MRO), Gregory Beischer, sat down to discuss the company’s upcoming second drilling campaign at the 64 North Project.

Paul Sun, President and CEO of Eminent Gold Corp. (EMNT) noted that sample results from Spanish Moon Project, show the potential for a large gold deposit.

Chris Frostad, President & CEO of Purepoint Uranium (TSXV:PTU) discussed the upcoming drill program at Red Willow Project in Saskatchewan.

Heritage Mining CEO, Peter Schloo talked about the company’s flagship the Drayton-Black Lake Project, which boasts 100 years’ worth of data which has never been digitized or looked at from a low-grade high-tonnage perspective.

JP Vargas de la Vega, Managing Director of Galan Lithium (ASX:GLN), spoke about a brand new pegmatite discovery at the Greenbushes South Project. While at the PDAC, the company announced its discovery at its lithium hotspot project in Western Australia, roughly five kilometres south from the largest lithium mine in world. The company generated 12 targets and found pegmatite discovery on the first one.

i-80 Gold (TSX:IAU) CEO, Ewan Downie talked about the first gold ore shipment out of Granite Creek and how the company is currently processing the ore at Nevada Gold Mine’s facility.

Cameron McCall, Executive Chairman and President of Macarthur Minerals (TSXV:MMS) sat down to discuss the optimistic feasibility study results on the Lake Giles Project.

Atac Resources (TSXV:ATC) President and CEO Graham Downs talked about its ongoing copper and high-grade gold exploration programs at its Nadaleen Gold Project in Yukon.

Managing Director of Rafaella Resources (ASX:RFR), Steven Turner, spoke about the opportunities and challenges of growing its presence in Canada.

Vancouver junior mineral explorer Faraday Copper (CSE:FDY) President and Chief Executive Officer, Paul Harbidge talked about rebranding, the company’s plans over the coming 12 to 18 months, and developing a pair of projects in mining-friendly U.S. jurisdictions.

Tesoro Gold (ASX:TSO) holds one of the largest and most prospective gold projects in Chile. Geoff McNamara, a Non-Executive Director with the company spoke about its El Zorro Project, a 1.1 million oz. open pittable project looking to grow to 2 million oz. gold in the next 24 to 36 months, drilling to start in next couple of weeks, scoping study out in 4 weeks.

Brunswick Exploration (TSXV:BRW) Chief Executive Officer Robert Wares discussed the company’s current lithium exploration plans, its inventory targets and future prospects.

Tara Christie, President and CEO of Banyan Gold (TSXV:BYN) discussed the drilling program underway at the Aurmac Property, Yukon. The updated Resource Estimate comprises a total inferred mineral resource of 3,990,000 ‎ounces of gold on the property.

Peter Clausi, VP of Capital Markets for Silver Bullet Mines (TSXV:SBMI) discussed bringing the Buckeye Mine online is the company’s primary focus. The fully funded mill is being commissioned.

Monument Mining (TSXV:MMY) President and CEO, Cathy Zhai shared news about its Selinsing Gold Property near Kuala Lumpur.

Managing Director of Golden Rim (ASX:GMR) Craig Mackay spoke about the company’s new project, acquired last year during the COVID pandemic.

Focus Graphite (TSXV:FMS)  is developing two of the most promising high-purity flake graphite projects in North America, both located in Quebec and its CEO Marc Roy spoke about the need to depend less on foreign countries for EV battery minerals.

Green River Gold (CSE:CCR) CEO and President. Perry Little spoke about the company’s magnetic survey, having just completed the second portion with results that showed a lot of nickel on their Quesnel nickel property.

Cassiar Gold (TSXV:GLDC) President and CEO, Marco Roque discussed recent drilling on the company’s flagship Cassiar Gold Property in northern British Columbia.

Richard Murphy, CEO of Manitou Gold (TSXV:MTU) provided an overview of the company’s projects, including the Goudreau Project in Ontario, where two past-producing mines bookend the project.

Mario Stifano, CEO of Galantas Gold (TSXV:GAL) discussed the company’s upcoming gold production planned for its Omagh project, which is located west of Belfast in Northern Ireland.

ArcPacific Resources (TSXV:ACP) is an exploration play with 100 per cent ownership of the LMSL Copper Gold and Silver Project in British Columbia.

Base metals focused company, Osisko Metals (TSXV:OM) is moving into feasibility for 2 projects. The company’s CEO, Robert Wares spoke about the Pine Point project, an assemblage of more than 50 open-pit and underground mines containing as much as 7b lb of lead and zinc proposed to be developed in Northwest Territories.

Macarthur Minerals (TSXV:MMS) CEO, Joe Phillips, spoke about its prospective Lake Giles Iron Project and its 1.3 billion tonnes magnetite resource.

Joel Freudman, CEO, Co-Founder and President of TRU Precious Metals (TSXV:TRU) spoke about building long-term shareholder value through exploration, potentially leading to exciting mergers and acquisitions opportunities. TRU is building copper-gold-silver assets in the Newfoundland in the highly prospective Central Newfoundland Gold Belt and has an option with TSX-listed Altius Minerals to purchase 100 per cent of the Golden Rose Project.

Perth-based resource exploration company Winsome Resources (ASX:WR1) turned to its Managing Director, Chris Evans to shed some light on the company’s flagship project as it moves towards expanding its maiden resource.

Lomiko Metals (TSXV:LMR) CEO, Belinda Labatte, talked about the company’s ongoing work at the La Loutre Project in Quebec. The project’s recently completed preliminary economic assessment indicated a mine life of 15 years producing 100,000 tonnes of graphite concentrate every year.

Ross McElroy, president and CEO of Fission Uranium (TSX:FCU) discussed the company’s uranium feasibility study that is currently underway at the Patterson Lake South Project in Saskatchewan’s Athabasca Basin.

Sitka Gold (CSE:SIG) is a junior gold, silver and copper explorer based in Canada. The company’s VP of Corporate Development, Mike Burke spoke on the company’s new discovery in Yukon. The RC Gold Project is an exploration venture highlighted by 220 metres of 1.17 g/t Au in the Tombstone Gold Belt region.

New Pacific Metals (TSX:NUAG) Founder and CEO, Dr Rui Feng, spoke about the start of drilling at its Silverstrike Project in Bolivia.

Xanadu Mines (TSX:XAM) Managing Director Colin Moorhead discussed the Kharmagtai Mine lies within Mongolia’s South Gobi porphyry copper province, which hosts most of the region’s known porphyry deposits, like the similar Oyu Tolgoi Mine operated by Rio Tinto.

Orange Minerals (ASX:OMX) Non-Executive Director, Conrad Karageorge, sat down with The Market Herald to talk about the latest completed drilling campaign at its Wiseman’s Creek Project in New South Wales.

Snowline Gold (CSE:SGD) CEO, Scott Berdahl, spoke about the company’s recent gold discovery at the Rogue Project in Yukon, which  showed visual gold in a drill core sample.

Elmer Stewart, President and CEO of Copper Fox Metals (TSXV:CUU), talked about commencing development work on the Eaglehead Project as the exploration crew readies for drilling.

Silvercorp Metals (TSX:SVM) Vice President Lon Shaver spoke about the company’s two mining districts in China; the flagship Ying Mining District and the GC Mine.

David Christie, President and CEO of Orford Mining (TSXV:ORM), spoke about several key projects in Quebec and shared results from the company’s winter drilling program at the Joutel Eagle Property.

Baselode Energy (TSXV:FIND) CEO, James Sykes, spoke about the company’s encouraging intercepts from ongoing drilling at the Hook Project in Saskatchewan’s Athabasca Basin.

Peter Dembicki, President and CEO of Tier One Silver (TSXV:TSLV) discussed the upcoming drill program at its flagship silver-gold project, Curibaya in southern Peru, comprised of approximately 16,800 hectares in a copper porphyry belt that hosts some of Peru’s largest porphyry deposits.

Northstar Gold (CSE:NSG) President and CEO, Brian Fowler, spoke with The Market Herald about the highly prospective opportunity at its Miller Gold Property near Kirkland Lake, Ontario.

Steve Robertson, President and CEO of Infinitum Copper (TSXV:INFI), spoke about three brand new discoveries at its flagship high-grade Cu-Au-Ag La Adelita Project in Sonora, Mexico.

Max Porterfield, President and CEO of Callinex Mines (TSXV:CNX), spoke about the Rainbow Deposit discovery at the Pine Bay Project, one of the highest grade copper discoveries in the world.

Mawson Gold (TSX:MAW) CEO, Ivan Fairhall, spoke about the company’s flagship Rajapalot Gold-Cobalt Project, based in Finland, which features an August 2021 Inferred Resource of 1.04 Moz grading 3 g/t AuEq.

Debuting its first discovery of 6.64 g/t gold over 30.48 metres from its flagship Reliance Gold Project in B.C., Endurance Gold Corporation (TSXV:EDG) President and CEO, Robert Boyd, spoke about the company’s acquisition, exploration and development of highly prospective North American mineral properties.

Altaley Mining Corporation (TSXV:ATLY) operates two 100-per-cent owned projects in Mexico covering gold, zinc, lead and silver, its flagship Tahuehueto Project in Durango, which will be one of the top 3 high-grade gold mines in the country once finalized, as well as its Campo Morado Mine in Guerrero.

Dominic Duffy, CEO, of Mandalay Resources (TSX:MND) spoke about the Björkdal mine in Skellefteå, Sweden with processing capacity of 1.3 million tonnes per annum, and production in 2021 of around 45,236 oz Au.

Alexandra Woodyer Sherron, CEO & President of Empress Royalty (TSXV:EMPR) introduced the company’s Manica Gold Mine in Mozambique, which had just moved into pre-production.

Investors don’t prosper on potential. Investors prosper on returns.

After several very lean years, mining investors (and mining companies) may be starting to see a light at the end of the tunnel.


The post And that’s a wrap: The Market Herald at PDAC 2022 appeared first on The Market Herald.

Read More

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Economics

Relief rally or sustained bounce?

In this video insight Roger discusses current market conditions with equities having rallied off the lows recently thanks to a lower oil price and a retreat…

Published

on

In this video insight Roger discusses current market conditions with equities having rallied off the lows recently thanks to a lower oil price and a retreat in bond yields amid fears of a recession. Have we reached the bottom yet?

Transcript

Roger Montgomery:

You have probably been relieved seeing the market rally over the last few days. The S&P500 Index made a low on June 17 and has since bounced almost eight per cent, dragging markets globally up with it. I was personally feeling pleased with my recent additional investment in the Polen Capital Global Small and Mid Cap Fund. But investing is a long-game, we’re in it for years not minutes.

Nevertheless, one of the biggest objections to investing during a crisis – which history has shown to be the best time – is the possibility the market could fall further. And it could. 

Equities have rallied off the lows recently thanks to a lower oil price and a retreat in bond yields amid fears of a recession. Recession concerns are dominating the narrative and even the head of the U.S. Federal Reserve, Jerome Powell has admitted the risk. Meanwhile google searches for “recession” have spiked ten-fold and are as high as during the Global Financial Crisis and the onset of the COVID pandemic.

Perhaps counterintuitively, recessions can be good news for equities particularly if prices have already fallen dramatically. That’s because, rather than focusing on the negative pressure on company earnings, investors instead look to the fall in bond yields and the consequent positive effect on present values.

But should we be getting too excited? Have we hit the bottom already? Even though I have recently invested additional capital, I am not certain we have hit the bottom. I can see reasonable arguments to suggest there could be more losses for equities. To be clear of course this would be a positive for anyone who considers themselves a net buyer of shares. The lower the price goes, the higher the subsequent return.

The U.S. Federal Funds futures curve has recently reduced its bet on additional aggressive rate hikes and is even forecasting an easing of interest rates next year. Along with the decline in the oil price and other commodities such as wheat, corn and copper, the reversal of rising bond rates suggests investor sentiment had switched recently from inflation to recession.

Unfortunately, the optimism is due to the U.S. Federal Reserve’s history of backing off rate rises whenever the equity market has fallen between 15 and 20 per cent. It’s known as the “Fed Put.”

It is true that the U.S. Federal Reserve eases aggressively when bear markets in equities precede recessions. However, it is also true that when the Fed has chickened out the circumstances were very different to today.

Since the 1990s, and certainly after the GFC, the primary problem confronting central banks and governments has been pallid organic economic growth and low inflation, and even the intermittent threat of deflation. Understandably, rate cuts make sense.

But prior to the 1990s the Fed’s response differed. In the 1970s for example persistent inflation meant Fed policy was aimed squarely at fighting inflation, with less concern for the impact on economic growth. Back then the Fed raised rates despite already large falls in the stock market and a weakening economy.

I cannot be sure of whether today’s U.S. central bank will be as callous as it was decades back however the reality is inflation has broken out and wage growth is accelerating with unions protesting and striking, risking a dangerous wage-price spiral.

So have we reached the bottom yet? Well, uncertainty about the Fed’s stance is sure to mean more volatility. Until we get a clear read on interest rates, the lows could easily be retested.

Read More

Continue Reading

Government

5 Top Biotech Stocks To Watch In July 2022

Amid choppy markets, could there be potential in these top biotech stocks?
The post 5 Top Biotech Stocks To Watch In July 2022 appeared first on Stock…

Published

on

Should Investors Be Watching These Top Biotech Stocks In The Stock Market Now?

Just as most people think that pandemic woes are behind us, we now have the emergence of the monkeypox. While this virus may not be as contagious as the coronavirus, there is still a real cause for concern. On Tuesday, the Centers for Disease Control and Prevention (CDC) announced the activation of an emergency operations unit for monkeypox. This signals the initial stages of a public health concern. Epidemiologist Dr. Eric Feigl-Ding believes that the number of cases could reach 100,000 worldwide by August. In light of these circumstances, biotech stocks could be gaining more attention in the stock market. 

Furthermore, the coronavirus is not going away anytime soon. Recently, the U.S. Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted that there is a need to modify the current strain composition of available COVID-19 vaccines to target the Omicron variant. If this is approved, vaccine makers such as Pfizer/BioNTech, and Moderna (NASDAQ: MRNA) will need to provide modified boosters of their coronavirus vaccines. In fact, Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) just announced a new vaccine supply agreement with the U.S. government. Under the agreement, the U.S. government will receive 105 million doses with an option of up to 195 million additional doses. With all this in mind, here are five of the top biotech stocks to note in the stock market today. 

Biotech Stocks For Your July 2022 Watchlist

Regeneron Pharmaceuticals 

biotech stocks to buy (regn stock)

First up, we have the integrated biotech company, Regeneron Pharmaceuticals. Essentially, the company discovers, invents, manufactures, and commercializes medicines for serious diseases. For the most part, its medicines and products aim to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular, and metabolic diseases. REGN stock has been trading sideways over the past year. 

Having said that, the company received a boost on Wednesday as the U.S. FDA has accepted for review the EYLEA Injection supplemental Biologics License Application for every 16-week 2 mg dosing regimen. This specifically caters to patients with diabetic retinopathy. Should this go according to plan, the 16-week dosing regimen could offer patients a potentially longer treatment interval. Also, it will allow doctors to have greater flexibility to individualize treatment. Given such a positive development, should investors be paying more attention to REGN stock?

[Read More] Stock Market Today: Dow Jones, S&P 500 Falter; Walgreens Stock Slides Despite Strong Quarter

Sanofi

best health care stocks to buy now (SNY stock)

Another top biotech name making waves this week is Sanofi. The France-based company engages in the research, development, and marketing of therapeutic solutions. Over the past week, there have been several key developments that could potentially excite investors. For starters, the company and GSK (NYSE: GSK) announced positive data from their vaccine trial last Friday. The vaccine candidate is the first to ever demonstrate efficacy in a placebo-controlled trial in an environment of high Omicron variant circulation. 

Furthermore, Sanofi’s Nexviadyme (avalglucosidase alfa) has recently gained marketing authorization from the European Commission. For the uninitiated, this is an enzyme replacement therapy for long-term treatment of both late-onset and infantile-onset Pompe disease. This is a significant development because Nexviadyme is the first and only newly approved medicine for Pompe disease in Europe since 2006. On that note, would you say that SNY stock is a top biotech stock to watch?

Novavax

best biotech stocks (NVAX stock)

Following that, let us look at the biotech company, Novavax. In detail, it promotes improved health globally through the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. Its recombinant technology platform harnesses the power and speed of genetic engineering. As a result, the company produces immunogenic nanoparticles designed to address urgent global health needs. That said, NVAX stock has been struggling to find its footing since the start of the year. 

During the VRBPAC meeting, Novavax highlighted data showing that its protein-based coronavirus vaccine showed epitopes across both the original strain and emerging variants. Therefore, it will be able to contribute to the generation of broadly cross-reacting antibodies. The company also provided pre-clinical data that suggests boosting with Novavax’s Omicron or prototype vaccine will induce an immune response against Omicron variants. Overall, there are reasons to believe that Novavax will close the second half of the year on a better note. With that in mind, would you consider adding NVAX stock to the top of your watchlist?

Arrowhead Pharmaceuticals 

ARWR stock

Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. It uses a portfolio of ribonucleic acid (RNA) chemistries and modes of delivery. Most of its therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. Those following the medical space would notice that gene therapies have been gaining popularity within the industry over the past few years. Hence, it would not be surprising if investors are taking note of Arrowhead. 

As a matter of fact, the company recently claimed that its experimental drug fazirsiran can reduce the accumulation of mutant protein known as Z-AAT by 83%. This result is based on an open-label phase 2 trial involving 16 volunteers with alpha1-antitrypsin deficiency disease. For now, there is still no approved treatment for such genetic liver disease. All in all, Arrowhead appears to be making strides in the right direction. Thus, should you be keeping a closer tab on ARWR stock?

[Read More] Best Long-Term Stocks To Buy Now? 5 Semiconductor Stocks To Know

Global Blood Therapeutics

gbt stock

To sum it all up, we have the biopharmaceutical company, Global Blood Therapeutics. As its name suggests, this is a company that specializes in blood-related treatments. The company is currently focused on Oxbryta, an FDA-approved medicine that inhibits sickle hemoglobin polymerization. In addition, it is also advancing its pipeline program in Sickle Cell Disease with inclacumab, and GBT021601. Impressively, GBT stock has been on bullish momentum lately, rising more than 28% within the past month.

Not to mention, the company announced on Thursday that it initiated the Phase 2 portion of its Phase 2/3 trial of GBT021601. The study aims to evaluate the safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of the drug. So far, the preclinical results and data have been encouraging. Smith-Whitley, the company’s head of research and development, believes the drug has “the potential to improve on the clinical results achieved with Oxbryta® at a lower daily dose.” If so, this would be a huge boost for the company as it continues to work towards its long-term goals. All things considered, is GBT stock a buy right now?

If you enjoyed this article and you’re interested in learning how to trade so you can have the best chance to profit consistently then you need to checkout this YouTube channel. CLICK HERE RIGHT NOW!!

The post 5 Top Biotech Stocks To Watch In July 2022 appeared first on Stock Market News, Quotes, Charts and Financial Information | StockMarket.com.

Read More

Continue Reading

Bonds

Bitcoin nears worst monthly losses since 2011 with BTC price at $19K

Bitcoin price action will seal monthly losses over 40% for the first time in 11 years if it closes at $19,000.
Bitcoin (BTC) drifted…

Published

on

Bitcoin price action will seal monthly losses over 40% for the first time in 11 years if it closes at $19,000.

Bitcoin (BTC) drifted further downhill into the June 30 Wall Street open as United States equities opened with a whimper.

BTC/USD 1-hour candle chart (Bitstamp). Source: TradingView

U.S. dollar returns to multi-decade highs

Data from Cointelegraph Markets Pro and TradingView followed BTC/USD as it abandoned $19,000 to hit its lowest in over ten days.

Bulls failed to preserve either $20,000 or $19,000 at the hands of limp U.S. stock market moves, the S&P 500 and Nasdaq Composite Index down 1.8% and 2.6% respectively at the time of writing.

At the same time, the U.S. dollar once again staged a comeback to fix a trajectory toward twenty-year highs seen this quarter.

The U.S. dollar index (DXY) was above 105.1 on the day, coming within just 0.2 points of its highest levels since 2002.

U.S. dollar index (DXY) 1-day candle chart. Source: TradingView

"The US dollar (DXY) looks set to test highs last seen in December 2002 as the short-term downtrend is broken convincingly amid risk markets' continued crumble," researche and trader Faisal Khan summarized on Twitter.

Data on inflation meanwhile once more suggested the worst could be behind the market.

As Cointelegraph reported, however, central banks began to acknowledge that the low rates seen before COVID-19 may never return.

Bulls' worst month in 11 years

With the majority of on-chain metrics now at historic lows, price data hinted how far BTC could theoretically go in a bear market increasingly unlike the rest.

Related: No flexing for Bitcoin Cash users as BCH loses 98% against Bitcoin

Should it close at current levels of $19,000, BTC/USD would seal monthly losses of over 40% for June 2022.

That would make it the worst June ever and the heaviest monthly losses since September 2011, data from TradingView and on-chain monitoring resource Coinglass confirms. 

Even March 2020 and the 2018 and 2014 bear markets were less severe on monthly timeframes. 40% drops were last seen when BTC/USD traded at $8.

BTC/USD monthly returns chart. Source: Coinglass

The views and opinions expressed here are solely those of the author and do not necessarily reflect the views of Cointelegraph.com. Every investment and trading move involves risk, you should conduct your own research when making a decision.

Read More

Continue Reading

Trending